Alector, Inc. (NASDAQ: ALEC)
$2.2500
-0.2700 ( -4.26% ) 1.9M
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
Market Data
Open
$2.2500
Previous close
$2.5200
Volume
1.9M
Market cap
$231.13M
Day range
$2.2250 - $2.5200
52 week range
$2.2250 - $8.9000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 04, 2024 |
4 | Insider transactions | 1 | Jun 04, 2024 |
4 | Insider transactions | 1 | Jun 04, 2024 |
4 | Insider transactions | 1 | May 31, 2024 |
8-k | 8K-related | 13 | May 08, 2024 |
10-q | Quarterly Reports | 48 | May 08, 2024 |
4 | Insider transactions | 1 | May 02, 2024 |
ars | Annual reports | 1 | Apr 25, 2024 |
def | Proxies and info statements | 16 | Apr 25, 2024 |
4 | Insider transactions | 1 | Mar 21, 2024 |